| Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: durable remissions with minimal toxicity V Mathews, B George, KM Lakshmi, A Viswabandya, A Bajel, ... Blood 107 (7), 2627-2632, 2006 | 413 | 2006 |
| Single-agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia: long-term follow-up data V Mathews, B George, E Chendamarai, KM Lakshmi, S Desire, ... Journal of Clinical Oncology 28 (24), 3866-3871, 2010 | 304 | 2010 |
| Acute myeloid leukaemia: challenges and real world data from India C Philip, B George, A Ganapule, A Korula, P Jain, AA Alex, KM Lakshmi, ... British journal of haematology 170 (1), 110-117, 2015 | 130 | 2015 |
| Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell … R Thirugnanam, B George, E Chendamarai, KM Lakshmi, ... Biology of Blood and Marrow Transplantation 15 (11), 1479-1484, 2009 | 114 | 2009 |
| Improved clinical outcomes of high risk β thalassemia major patients undergoing a HLA matched related allogeneic stem cell transplant with a treosulfan based conditioning … V Mathews, B George, A Viswabandya, A Abraham, R Ahmed, ... PloS one 8 (4), e61637, 2013 | 96 | 2013 |
| Psychometric analysis of the functional independence score in haemophilia (FISH) PM Poonnoose, R Thomas, SN Keshava, RS Cherian, S Padankatti, ... Haemophilia 13 (5), 620-626, 2007 | 94 | 2007 |
| Fludarabine and cyclophosphamide based reduced intensity conditioning (RIC) regimens reduce rejection and improve outcome in Indian patients undergoing allogeneic stem cell … B George, V Mathews, A Viswabandya, ML Kavitha, A Srivastava, ... Bone marrow transplantation 40 (1), 13-18, 2007 | 88 | 2007 |
| Long-term outcome following splenectomy for chronic and persistent immune thrombocytopenia (ITP) in adults and children: splenectomy in ITP R Ahmed, AJ Devasia, A Viswabandya, KM Lakshmi, A Abraham, S Karl, ... Annals of hematology 95, 1429-1434, 2016 | 86 | 2016 |
| Dapsone for chronic idiopathic thrombocytopenic purpura in children and adults–a report on 90 patients S Damodar, A Viswabandya, B George, V Mathews, M Chandy, ... European journal of haematology 75 (4), 328-331, 2005 | 82 | 2005 |
| Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol A Bajel, B George, V Mathews, A Viswabandya, ML Kavitha, A Srivastava, ... Pediatric blood & cancer 51 (5), 621-625, 2008 | 77 | 2008 |
| A new stratification strategy that identifies a subset of class III patients with an adverse prognosis among children with β thalassemia major undergoing a matched related … V Mathews, B George, U Deotare, KM Lakshmi, A Viswabandya, D Daniel, ... Biology of Blood and Marrow Transplantation 13 (8), 889-894, 2007 | 76 | 2007 |
| Role of minimal residual disease monitoring in acute promyelocytic leukemia treated with arsenic trioxide in frontline therapy E Chendamarai, P Balasubramanian, B George, A Viswabandya, ... Blood, The Journal of the American Society of Hematology 119 (15), 3413-3419, 2012 | 70 | 2012 |
| Reduced-intensity conditioning and dual T lymphocyte suppression with antithymocyte globulin and post-transplant cyclophosphamide as graft-versus-host disease prophylaxis in … AD Law, MQ Salas, W Lam, FV Michelis, S Thyagu, JH Lipton, R Kumar, ... Biology of Blood and Marrow Transplantation 24 (11), 2259-2264, 2018 | 68 | 2018 |
| Treatment of acute promyelocytic leukemia with single-agent arsenic trioxide V Mathews, E Chendamarai, B George, A Viswabandya, A Srivastava Mediterranean journal of hematology and infectious diseases 3 (1), 2011 | 64 | 2011 |
| The mutational landscape of accelerated-and blast-phase myeloproliferative neoplasms impacts patient outcomes CJ McNamara, T Panzarella, JA Kennedy, A Arruda, JO Claudio, ... Blood advances 2 (20), 2658-2671, 2018 | 62 | 2018 |
| Ruxolitinib therapy followed by reduced-intensity conditioning for hematopoietic cell transplantation for myelofibrosis: Myeloproliferative Disorders Research Consortium 114 Study V Gupta, HE Kosiorek, A Mead, RB Klisovic, JP Galvin, D Berenzon, ... Biology of Blood and Marrow Transplantation 25 (2), 256-264, 2019 | 54 | 2019 |
| RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia A Abraham, S Varatharajan, S Karathedath, C Philip, KM Lakshmi, ... Pharmacogenomics 16 (8), 877-890, 2015 | 50 | 2015 |
| Hepatotoxicity profile of single agent arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia, its impact on clinical outcome and the effect of … V Mathews, S Desire, B George, KM Lakshmi, JG Rao, A Viswabandya, ... Leukemia 20 (5), 881-883, 2006 | 50 | 2006 |
| Correlating clinical manifestations with factor levels in rare bleeding disorders: a report from Southern India A Viswabandya, S Baidya, SC Nair, A Abraham, B George, V Mathews, ... Haemophilia 18 (3), e195-e200, 2012 | 48 | 2012 |
| Plasmacytoid dendritic cell count on day 28 in HLA-matched related allogeneic peripheral blood stem cell transplant predicts the incidence of acute and chronic GVHD R Rajasekar, V Mathews, KM Lakshmi, S Sellathamby, B George, ... Biology of Blood and Marrow Transplantation 14 (3), 344-350, 2008 | 47 | 2008 |
